Abstract
Tamoxifen has been in the center of management of hormone-sensitive breast cancer. Furthermore, it represents the best example of chemo-prevention: It reduces the incidence of invasive breast cancer. However, it has some side effects, several of them are severe. Oncologists, hematologists, internal medicine specialists and gynecologists must know this agent in detail. Authors report a very rare side effect, thrombocytopenia and discuss it briefly.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Early Breast Cancer Trialists’ Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative Group. Lancet 1998;351:1451–67
Fisher B, Constantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 1998;90:1371–88
Goetz MP, Erlichman C, Loprinzi CL. Pharmacology of endocrine manipulation. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer principle and practice of Oncology. 7th ed. Philadelphia: Lippincott Williams and Wilkins Inc.; 2005. p 457–68
Ragaz J, Buskard N, Manji M. Thrombocytopenia after combination therapy with aminoglutethimide and tamoxifen: which drug is to blame? Cancer Treat Rep 1984;68:1015–16
Yao JC, Thomakos N, McLaughlin P, et al. Tamoxifen-induced thrombocytopenia. Am J Clin Oncol 1999;22:529–32
Candido A, Bussa S, Tartaglione R, et al. Tamoxifen-induced immune-mediated platelet destruction: a case report. Tumori 1993;79:231–234
Handin RI. Dısorders of the platelet and vessel wall. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, editors. Harrıson’s principles of internal medicine. 16th ed. New York: McGraw-Hill Companies Inc.; 2005. p 673–80
Erman M, Abali H, Oran B, et al. Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state? Ann Oncol 2004;15:1622–26
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nasıroğlu, N., Pamukçuoğlu, M., Abalı, H. et al. Tamoxifen induced-thrombocytopenia: it does occur. Med Oncol 24, 453–454 (2007). https://doi.org/10.1007/s12032-007-0013-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-007-0013-0